Review of Liver Protection Drugs for Tuberculosis Treatment
Author Information
Author(s): Liu Qin, Garner Paul, Wang Yang, Huang Binghua, Smith Helen
Primary Institution: Chongqing Medical University
Hypothesis
What is the evidence base for the use of liver protection drugs in tuberculosis patients?
Conclusion
There is no reliable evidence to support prescription of drugs or herbs to prevent liver damage in people on tuberculosis treatment.
Supporting Evidence
- Eighty-five research articles evaluated liver protection drugs in tuberculosis patients.
- All studies were small and poorly conducted, measuring only intermediate outcomes.
- No studies in China were placebo controlled.
Takeaway
This study looked at different medicines that are supposed to protect the liver during tuberculosis treatment, but found that they don't really work and might even be harmful.
Methodology
A systematic review of research articles evaluating liver protection drugs for tuberculosis treatment.
Potential Biases
Many studies did not report adverse events or methods for monitoring them.
Limitations
Most studies were small, poorly conducted, and lacked proper controls.
Participant Demographics
Studies primarily conducted in China, with some in India, Russia, and Ukraine.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website